二甲双胍调节斑马鱼中非酒精性脂肪性肝病相关肝细胞癌的先天免疫介导炎症和早期进展
研究利用光学透明斑马鱼构建高脂饮食联合肝细胞特异性激活β-连环蛋白的NAFLD/NASH-HCC模型,活体成像观察肝脏炎症与肿瘤早期进展。发现高脂饮食增加肝脏大小、血管生成、微核形成和中性粒细胞浸润,改变巨噬细胞形态与极化并增加TNFα阳性巨噬细胞,降低T细胞密度;二甲双胍改变巨噬细胞极化、减小肝脏大小、减少微核形成并逆转T细胞密度下降。提示饮食通过改变巨噬细胞极化加剧肝脏炎症微环境和癌症进展,二甲双胍可能通过调节免疫反应影响肿瘤监视。
要点
- 高脂饮食诱导斑马鱼NAFLD/NASH相关HCC模型肝脏增大、血管生成增强、微核形成及中性粒细胞浸润。
- 高脂饮食增加肝脏TNFα阳性巨噬细胞并降低T细胞密度,二甲双胍可逆转T细胞密度下降。
- 二甲双胍改变巨噬细胞极化、减小肝脏大小并减少微核形成,可能影响肿瘤监视。
核心结论
- 饮食改变巨噬细胞极化并加剧斑马鱼NAFLD/NASH相关HCC模型的肝脏炎症微环境和癌症进展。
- 二甲双胍特异性影响饮食诱导的进展,通过影响巨噬细胞极化和T细胞浸润调节免疫反应,提示可能影响肿瘤监视。
研究设计与样本
- 研究采用光学透明斑马鱼,结合高脂饮食与肝细胞特异性激活β-连环蛋白的转基因HCC模型,利用活体成像观察肝脏炎症和疾病进展。
- 评估指标包括肝脏大小、血管生成、微核形成和炎症,并检测二甲双胍对免疫细胞组成和早期HCC进展的影响。
主要发现
- 高脂饮食诱导肝脏大小增加、血管生成增强、微核形成和中性粒细胞浸润。
- 高脂饮食不影响巨噬细胞数量,但改变巨噬细胞形态和极化,增加肝脏相关TNFα阳性巨噬细胞。
- 二甲双胍改变巨噬细胞极化,减小NAFLD/NASH相关HCC幼鱼肝脏大小并减少微核形成。
- 高脂饮食降低肝脏T细胞密度,二甲双胍治疗可逆转该降低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH) is an increasing clinical problem associated with progression to hepatocellular carcinoma (HCC). The effect of a high-fat diet on the early immune response in HCC is poorly understood, while the role of metformin in treating NAFLD and HCC remains controversial. Herein, we visualized the early immune responses in the liver and the effect of metformin on progression of HCC using optically transparent zebrafish. METHODS: We used live imaging to visualize liver inflammation and disease progression in a NAFLD/NASH-HCC zebrafish model. We combined a high-fat diet with a transgenic zebrafish HCC model induced by hepatocyte-specific activated beta-catenin and assessed liver size, angiogenesis, micronuclei formation and inflammation in the liver. In addition, we probed the effects of metformin on immune cell composition and early HCC progression. RESULTS: We found that a high-fat diet induced an increase in liver size, enhanced angiogenesis, micronuclei formation and neutrophil infiltration in the liver. Although macrophage number was not affected by diet, a high-fat diet induced changes in macrophage morphology and polarization with an increase in liver associated TNFα-positive macrophages. Treatment with metformin altered macrophage polarization, reduced liver size and reduced micronuclei formation in NAFLD/NASH-associated HCC larvae. Moreover, a high-fat diet reduced T cell density in the liver, which was reversed by treatment with metformin. CONCLUSIONS: These findings suggest that diet alters macrophage polarization and exacerbates the liver inflammatory microenvironment and cancer progression in a zebrafish model of NAFLD/NASH-associated HCC. Metformin specifically affects the progression induced by diet and modulates the immune response by affecting macrophage polarization and T cell infiltration, suggesting possible effects of metformin on tumor surveillance. LAY SUMMARY: This paper reports a new zebrafish model that can be used to study the effects of diet on liver cancer. We found that a high-fat diet promotes non-resolving inflammation in the liver and enhances cancer progression. In addition, we found that metformin, a drug used to treat diabetes, inhibits high-fat diet-induced cancer progression in this model, by reducing diet-induced non-resolving inflammation and potentially restoring tumor surveillance.
引用
- de Oliveira S, Houseright RA, Graves AL, et al. Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish. J Hepatol. 2018. PMID: 30572006. doi:10.1016/j.jhep.2018.11.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。